Haemophilus B and hepatitis B vaccine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 15:27, 19 June 2020 (consistent citation formatting). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Haemophilus B and hepatitis B vaccine
Combination of
Hib vaccineVaccine
Hepatitis B vaccineVaccine
Clinical data
Trade namesComvax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
Intramuscular injection
ATC code
Identifiers
ChemSpider
  • none

Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.

A branded formulation, Comvax, was marketed in the USA by Merck.[2][3] It was discontinued in 2014.[4]

References

  1. ^ "Comvax". Drugs.com. Retrieved 15 July 2018.
  2. ^ "Notice to Readers FDA Approval for Infants of a Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant) Combined Vaccine". Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 7 February 1997. pp. 107–109. Retrieved 15 July 2018.
  3. ^ "Comvax package insert" (PDF). Retrieved 15 July 2018.
  4. ^ Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 7203587. doi:10.1155/2016/7203587. PMC 4745871. PMID 26904695.{{cite journal}}: CS1 maint: unflagged free DOI (link)